C4 Therapeutics Inc Revenue per Employee (CCCC), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


C4 Therapeutics Inc   (NASDAQ: CCCC)
 

C4 Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 2.75% in the second quarter 2026, year on year to cumulative value of $35 million, C4 Therapeutics Inc 's revenue per employee grew on a trailing twelve months basis to $ 336,913. The productivity of C4 Therapeutics Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 286 other companies have achieved higher revenue per employee. While C4 Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 1868 to 2318. C4 Therapeutics Inc has 104 employees.


What is Sales per Employee Ratio?







CCCC Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change 2.75 % -15 % 112.79 % -26.9 % -46.17 %
Sales per Employee (TTM) $ 336,913 335,202 345,644 289,500 329,231
CCCC's Total Ranking # 2318 # 1868 # 1578 # 2355 # 1982
Seq. Revenue Change 7.95 % -44.15 % -1.91 % 73.76 % -10.71 %


Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 35
Healthcare Sector # 287
Overall Market # 2318

Revenue per Employee Statistics
High Average Low
$ 481,404 $ 295,968 $ 81,221
(Jun 30 2022)   (Sep 30 2020)



Financial Statements
C4 Therapeutics Inc 's Revenue MRQ $ 7 Millions Visit CCCC's Income Statement
C4 Therapeutics Inc 's Revenues TTM $ 35 Millions Visit CCCC's aggregate revenue growth
What are CCCC's Sales? Visit CCCC's Sales by Segment




Other Ratios
C4 Therapeutics Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
CCCC's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for CCCC's Competitors
Revenue per Employee for CCCC's Suppliers
Revenue per Employee for CCCC's Customers

You may also want to know
CCCC's Sales Growth Rates CCCC's Pe Price to earnings ratio CCCC's Receivables Turnover Ratio CCCC's Stock Quote
CCCC's Net Income Growth Rates CCCC's Ps Price to Sales ratio CCCC's Sales per Employee CCCC's Asset Turnover Ratio
CCCC's Net Margin CCCC's Pb Price to Book ratio CCCC's Financial Strength Ratios CCCC's Dividend Payout Ratio
Date modified: 2026-09-04T10:07:19+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Waters Corporation  587,879.62 $ 4,644.249  Million 7,900 
Phibro Animal Health Corporation  582,288.29 $ 1,516.861  Million 2,605 
Rhythm Pharmaceuticals Inc   579,512.08 $ 239.918  Million 414 
Macrogenics Inc   572,266.21 $ 167.674  Million 293 
Cardiff Lexington Corporation  567,380.00 $ 10.213  Million 18 
Embecta Corp   551,189.19 $ 1,019.700  Million 1,850 
Iridex Corp  548,860.22 $ 51.044  Million 93 
Henry Schein Inc   544,080.00 $ 13,602.000  Million 25,000 
Enanta Pharmaceuticals Inc  543,816.67 $ 65.258  Million 120 
Instil Bio Inc   527,529.41 $ 8.968  Million 17 
Globus Medical Inc   524,155.67 $ 3,144.934  Million 6,000 
10x Genomics Inc   523,400.68 $ 616.566  Million 1,178 
Iradimed Corporation  520,114.23 $ 86.339  Million 166 
Alpha Pro Tech Ltd   505,723.58 $ 62.204  Million 123 
Angiodynamics Inc   502,731.01 $ 317.726  Million 632 
Biofrontera Inc   499,521.74 $ 45.956  Million 92 
Accuray Incorporated  495,467.24 $ 400.833  Million 809 
Resmed Inc   495,001.76 $ 5,628.170  Million 11,370 
Adaptive Biotechnologies Corporation  493,719.55 $ 308.081  Million 624 
Viatris Inc   491,243.33 $ 14,737.300  Million 30,000 
Invivyd Inc   478,401.64 $ 58.365  Million 122 
Maravai Lifesciences Holdings Inc   477,898.85 $ 207.886  Million 435 
Moderna Inc   474,042.55 $ 2,228.000  Million 4,700 
Guardant Health Inc   472,108.94 $ 1,183.105  Million 2,506 
Neuropace Inc   471,866.03 $ 98.620  Million 209 
Skinhealth Systems Inc   471,817.29 $ 289.224  Million 613 
Pelthos Therapeutics Inc   470,695.65 $ 43.304  Million 92 
Inogen Inc   470,523.24 $ 354.304  Million 753 
Regenxbio Inc   470,301.89 $ 174.482  Million 371 
4d Molecular Therapeutics Inc   469,428.57 $ 92.008  Million 196 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.